Goldman Sachs analyst Terence Flynn reiterated a Neutral rating and $41.00 price target on Pfizer (NYSE: PFE) offering several different ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE